Cognitive Research Corporation

Cognitive Research Corporation (CRC) is a full-service Contract Research Organization (CRO) headquartered in St. Petersburg, Florida. The company employs 13 people and generates an estimated $50 million in annual revenue. CRC specializes in the development of drugs for central nervous system (CNS) and neuro disorders. CRC provides comprehensive services for clinical trials from Phase I to Phase IV, encompassing all aspects of the drug development process. Their expertise includes embedded assessments and cross-functional CRO services, aimed at streamlining trial execution for sponsors. They boast a network of over 300 clinical research sites across the globe, all equipped and trained to conduct CRC clinical trials. CRC's deep scientific understanding of neuroscience, combined with decades of operational experience, has resulted in a successful track record. The company has supported over 450 clinical trials, leading to 30+ Investigational New Drug (IND) applications and 14+ New Drug Application (NDA) submissions and approvals. Their focused therapeutic area has allowed them to build strong relationships with leading neuro/CNS research sites. For career opportunities, interested candidates can submit their CV to [email protected]. CRC's website can be found at cogres.com.